The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Waltz Health and Noom Launch Affordable GLP-1 Weight Loss Program
Waltz Health is partnering with Noom to launch a comprehensive and affordable weight loss program focused on GLP-1 management. Utilizing Waltz Connect, the initiative aims to enhance price transparency and accessibility for employees needing GLP-1 prescriptions, while also reducing costs for employers. The program is part of Noom Med, which combines evidence-based obesity care with behavior change strategies to promote sustained weight loss.
medicare coverage of weight loss drugs could cost 35 billion by 2034
If Medicare covers anti-obesity medications, federal spending could rise by $35 billion from 2026 to 2034, with direct costs increasing from $1.6 billion to $7.1 billion. Despite the potential health benefits for over 12.5 million beneficiaries, the savings from improved health would be minimal compared to the costs.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.